| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 肝病类(元) | 150,762,514.37 | 227,168,147.89 | 165,315,327.17 |
| 高端氟产品(元) | 6,622,251.40 | 3,070,641.04 | 2,214,779.68 |
| 技术服务费(元) | 13,463,669.11 | 37,764,995.00 | 29,032,148.93 |
| 抗菌类(元) | 89,423,373.50 | 119,019,101.15 | 85,858,326.52 |
| 抗肿瘤类(元) | 6,873,479.28 | 11,622,902.38 | 3,016,604.85 |
| 前列腺素类(元) | 23,338,640.37 | 22,080,114.51 | 15,011,966.74 |
| 神经系统类(元) | 11,521,527.80 | 12,213,665.87 | 4,128,304.06 |
| 痛风类(元) | 55,231,007.33 | 77,687,127.16 | 40,613,948.17 |
| 心脑血管类(元) | 91,278,465.60 | 196,867,149.79 | 103,222,883.12 |
| 呼吸系统类(元) | 286,246.86 | - | - |
| 其他类(元) | 32,998,534.80 | 87,794,464.11 | 43,979,525.13 |
| 营业成本(元) | |||
| 肝病类(元) | 42,010,906.67 | 58,089,323.58 | 40,826,769.75 |
| 高端氟产品(元) | 1,841,927.89 | 617,713.02 | 410,874.92 |
| 技术服务费(元) | 422,591.71 | 18,250,237.54 | 2,177,146.05 |
| 抗菌类(元) | 36,298,423.92 | 58,450,577.85 | 43,062,858.88 |
| 抗肿瘤类(元) | 2,708,538.73 | 5,709,280.44 | 1,360,507.13 |
| 前列腺素类(元) | 5,500,393.31 | 5,252,425.65 | 2,536,981.49 |
| 神经系统类(元) | 7,360,156.99 | 8,482,195.02 | 3,290,097.77 |
| 痛风类(元) | 34,481,112.18 | 64,365,834.53 | 29,747,960.75 |
| 心脑血管类(元) | 57,675,096.54 | 103,708,957.09 | 49,994,929.83 |
| 呼吸系统类(元) | 262,904.90 | - | - |
| 其他类(元) | 13,077,167.51 | 41,054,278.91 | 24,510,452.60 |
| 毛利(元) | |||
| 肝病类(元) | 108,751,607.70 | 169,078,824.31 | 124,488,557.42 |
| 高端氟产品(元) | 4,780,323.51 | 2,452,928.02 | 1,803,904.76 |
| 技术服务费(元) | 13,041,077.40 | 19,514,757.46 | 26,855,002.88 |
| 抗菌类(元) | 53,124,949.58 | 60,568,523.30 | 42,795,467.64 |
| 抗肿瘤类(元) | 4,164,940.55 | 5,913,621.94 | 1,656,097.72 |
| 前列腺素类(元) | 17,838,247.06 | 16,827,688.86 | 12,474,985.25 |
| 神经系统类(元) | 4,161,370.81 | 3,731,470.85 | 838,206.29 |
| 痛风类(元) | 20,749,895.15 | 13,321,292.63 | 10,865,987.42 |
| 心脑血管类(元) | 33,603,369.06 | 93,158,192.70 | 53,227,953.29 |
| 呼吸系统类(元) | 23,341.96 | - | - |
| 其他类(元) | 19,921,367.29 | 46,740,185.20 | 19,469,072.53 |
| 毛利率(%) | |||
| 肝病类(%) | 72.13 | 74.43 | 75.30 |
| 高端氟产品(%) | 72.19 | 79.88 | 81.45 |
| 技术服务费(%) | 96.86 | 51.67 | 92.50 |
| 抗菌类(%) | 59.41 | 50.89 | 49.84 |
| 抗肿瘤类(%) | 60.59 | 50.88 | 54.90 |
| 前列腺素类(%) | 76.43 | 76.21 | 83.10 |
| 神经系统类(%) | 36.12 | 30.55 | 20.30 |
| 痛风类(%) | 37.57 | 17.15 | 26.75 |
| 心脑血管类(%) | 36.81 | 47.32 | 51.57 |
| 呼吸系统类(%) | 8.15 | - | - |
| 其他类(%) | 60.37 | 53.24 | 44.27 |
| 收入构成(%) | |||
| 肝病类(%) | 31.29 | 28.56 | 33.57 |
| 高端氟产品(%) | 1.37 | 0.39 | 0.45 |
| 技术服务费(%) | 2.79 | 4.75 | 5.90 |
| 抗菌类(%) | 18.56 | 14.97 | 17.44 |
| 抗肿瘤类(%) | 1.43 | 1.46 | 0.61 |
| 前列腺素类(%) | 4.84 | 2.78 | 3.05 |
| 神经系统类(%) | 2.39 | 1.54 | 0.84 |
| 痛风类(%) | 11.46 | 9.77 | 8.25 |
| 心脑血管类(%) | 18.95 | 24.75 | 20.96 |
| 呼吸系统类(%) | 0.06 | - | - |
| 其他类(%) | 6.85 | 11.04 | 8.93 |
| 毛利构成(%) | |||
| 肝病类(%) | 38.82 | 39.20 | 42.27 |
| 高端氟产品(%) | 1.71 | 0.57 | 0.61 |
| 技术服务费(%) | 4.65 | 4.52 | 9.12 |
| 抗菌类(%) | 18.96 | 14.04 | 14.53 |
| 抗肿瘤类(%) | 1.49 | 1.37 | 0.56 |
| 前列腺素类(%) | 6.37 | 3.90 | 4.24 |
| 神经系统类(%) | 1.49 | 0.87 | 0.28 |
| 痛风类(%) | 7.41 | 3.09 | 3.69 |
| 心脑血管类(%) | 11.99 | 21.60 | 18.08 |
| 呼吸系统类(%) | 0.01 | - | - |
| 其他类(%) | 7.11 | 10.84 | 6.61 |